HHS on Friday finalized a rule that expands and clarifies what clinical-trial data legally needs to be made public. The goal is to help scientists, doctors and patients learn more about ongoing research and potentially ease access to experimental treatments.
A 2007 law required certain universities and manufacturers to report their results. But some exemptions and lax enforcement caused few to follow through. A Duke University study in 2015 found that only 13.4% of trials reported summary results within the mandated 12-month time-frame following the end of a trial.
